FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106585 [Registered on: 19/03/2026] Trial Registered Prospectively
Last Modified On: 18/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA)
Behavioral 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Role of Diet and Resistance Training in Preventing Relapse in Ulcerative Colitis with Sarcopenia 
Scientific Title of Study   Effect of dietary intervention and resistance training on relapse rate among adult patients of Ulcerative colitis with sarcopenia : A randomized controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anmol Saini 
Designation  Senior resident  
Affiliation  ABVIMS and Dr RML hospital 
Address  ABVIMS and Dr RML Hospital
Baba Kharak Singh Rd, near Gurudwara Bangla Sahib, Ram Manohar Lohia Hospital, Type III, Connaught Place, New Delhi, Delhi 110001
Central
DELHI
110001
India 
Phone  9958964544  
Fax    
Email  saini.anmol94@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Preeti Rajpoot 
Designation  Professor  
Affiliation  ABVIMS and Dr RML hospital 
Address  ABVIMS and Dr RML Hospital
Baba Kharak Singh Rd, near Gurudwara Bangla Sahib, Ram Manohar Lohia Hospital, Type III, Connaught Place, New Delhi, Delhi 110001
Central
DELHI
110001
India 
Phone  7570096707  
Fax    
Email  prajpoot15@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Anmol Saini 
Designation  Senior resident  
Affiliation  ABVIMS and Dr RML hospital 
Address  ABVIMS and Dr RML Hospital
Baba Kharak Singh Rd, near Gurudwara Bangla Sahib, Ram Manohar Lohia Hospital, Type III, Connaught Place, New Delhi, Delhi 110001

DELHI
110001
India 
Phone  9958964544  
Fax    
Email  saini.anmol94@gmail.com  
 
Source of Monetary or Material Support  
nil  
 
Primary Sponsor  
Name  Abvims and Dr Rml hospital 
Address  Baba Kharak Singh Road near Gurudwara Bangla Sahib Ram Manohar Lohia Hospital, Type III Connaught Place New Delhi Delhi 110001 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anmol saini  Nursing home room number 10, ABVIMS and Dr RML hospital, New Delhi  Baba Kharak Singh Rd, near Gurudwara Bangla Sahib, Ram Manohar Lohia Hospital, Type III, Connaught Place, New Delhi, Delhi 110001
Central
DELHI 
01123404040

diary.section@rmlh.nic.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC,ABVIMS,DR RML Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K51||Ulcerative colitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  High protein diet and resistance training   DietaryPlan: Individualized by a clinical dietitian based on total energy requirement (25–35 kcal/kg/day). High- quality protein sources (whey, dairy, soy, fish, eggs) will be emphasized according to the vegetarian/non-vegetarian status of the patient. Adherence will be monitored telephonically weekly and monthly by the dietitian. Exercise Plan Progressive resistance training- Structured Individualized rehabilitation program for 40 minutes including warm up and cool down period comprising of : - Warm-Up (5 minutes) - Upper Limb Strengthening exercises (20 minutes) : targeting shoulders stabiliser, arms & forearm flexor & extensors & intrinsic muscle of hands, back extensor - Lower Limb Strengthening (12 minutes): targeting gastrosoleus, quadriceps , gluteal muscle and coregroup - Cool-Down and Stretch (3 minutes) - Frequency: 3 sessions/week on alternating days. Two sets of 10-12 repetition - Intensity: Start at 40–60% of 1RM or 3–5 RPE, progress as tolerated. - Progression cues: Increase resistance when completing all repetition easily without fatigue. - 30 minutes walking on alternate days Supervised sessions will be conducted weekly initially and then 4 weekly for 12 months under the supervision of Department of PMR. Adherence will be monitored by asking patients to send their videos doing resistance training exercises. 
Comparator Agent  Routine activity and diet   30 min of walking or other moderate intensity exercise 5 days a week. Continue taking your normal routine diet 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Age 18 to 70 years
Established diagnosis of Ulcerative colitis with standard criteria (Colonoscopy + histology,
Ancillary investigations (ESR, CRP, Faecal calprotectin).
Inactive ulcerative colitis
Patients should be in remission at least 4 weeks prior to enrolment and on standard of care
treatment
Presence of sarcopenia at screening defined by South Asian working action group- Sarcopenia
(SWAG- SARCO) criteria 
 
ExclusionCriteria 
Details  1.Active disease at enrollment
2. Clinical relapse or requirement for induction therapy or steroids within prior 4 weeks
3. Patients on biologicals
4. Chronic diseases that may affect muscle mass such as CLD, CHF, CKD, patients with
rheumatic diseases
5. Intestinal obstruction
6. Toxic megacolon
7. Malignancy
8. Pregnancy
9. Neurological diseases like CVA, Parkinson’s disease

 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
To evaluate clinical relapse rates among adult patients of Ulcerative Colitis with sarcopenia
randomized to high-protein diet plus structured resistance training programme versus standard
of care. 
3,6 and 12 months. 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate change in muscle mass as determined by BIA, muscle strength as determined by handgrip & physical function as determined by gait speed between the two groups
 
3, 6 & 12 months 
To assess the change in quality of life between the two groups using SF 36 questionnaire
 
baseline & 12 months  
To determine the need for biologicals/colectomy in both group  3, 6 & 12 months. 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   31/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Improving muscle mass through nutrition, exercise, and optimized therapy may exert anti-

inflammatory and immunomodulatory effects, improving disease activity indices in patients of UC

and thereby preventing relapse . This study aims to investigate the effect of a combined dietary intervention and structured exercise

regimen on the prevention of disease relapse in IBD patients with sarcopenia, thereby providing

evidence for targeted, multidisciplinary management strategies in this high-risk population.

 
Close